Showing results (561-570 of 739) with videos related to

Sort By:
Pageof 74
Molecular Therapy. Oncology|September 3, 2024
Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapySalvatore Fiorenza, Sheryl Y T Lim, George S Laszlo, et al.
Blood Neoplasia|June 19, 2025
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasmSuravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, et al.
Blood|July 13, 2013
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remissionRoland B Walter, Sarah A Buckley, John M Pagel, et al.
Plos One|January 16, 2013
AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicinDavid B Rosen, Kimberly H Harrington, James A Cordeiro, et al.
Leukemia|August 12, 2022
Comparison of scoring systems evaluating suitability for intensive chemotherapy in adults with acute myeloid leukemia-a Grand Ouest Against Leukemia (GOAL) studyChristophe Desprez, Jérémie Riou, Pierre Peterlin, et al.
British Journal of Haematology|April 10, 2015
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of ageSarah A Buckley, Raya Mawad, Ted A Gooley, et al.
Vaccine|July 3, 2018
Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding womenRebecca C Brady, Lisa A Jackson, Sharon E Frey, et al.
JAMA Network Open|January 14, 2021
Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical TrialKenneth E Schmader, Christine K Liu, Theresa Harrington, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2014
Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapyMegan Othus, Frederick R Appelbaum, Stephen H Petersdorf, et al.
Transplantation and Cellular Therapy|May 8, 2021
Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal InfectionEmily S Ford, Elizabeth R Duke, Guang-Shing Cheng, et al.
Pageof 74